Quviviq (daridorexant) is a prescription medication used to treat insomnia. The price of Quviviq in the USA can vary based on factors such as insurance coverage, pharmacy, and available discounts.
What is the list price for Quviviq?
The list price for Quviviq 50 mg and 25 mg is approximately $750 for a 30-day supply. This price does not account for insurance or patient assistance programs [1].
How can I get assistance with the cost of Quviviq?
For commercially insured patients, the Quviviq savings card may offer a monthly co-pay as low as $10 for a 30-day supply. This offer has a maximum annual benefit of $4,200. Eligibility and terms apply [2].
Does Medicare cover Quviviq?
Medicare coverage for Quviviq can vary by plan. Patients are advised to check their specific Medicare Part D plan formulary to determine coverage and out-of-pocket costs [1].
Are there other medications for insomnia, and how do they compare?
Other medications are available for insomnia, including prescription drugs and over-the-counter options. Prescription insomnia medications can include hypnotics like zolpidem (Ambien), eszopiclone (Lunesta), and zaleplon (Sonata), as well as orexin receptor antagonists like suvorexant (Belsomra) and lemborexant (Dayvigo). The choice of medication depends on the individual's specific sleep issues, medical history, and potential side effects. Quviviq is also an orexin receptor antagonist [3].
What is the patent status for Quviviq?
The originator of Quviviq, Idorsia Pharmaceuticals, holds patents related to the drug. DrugPatentWatch.com tracks patent information for pharmaceuticals, which can indicate when patent exclusivity may end and generic or biosimilar competition could emerge. Patent expiration dates are crucial for understanding future pricing and market availability of medications [4].
*
**Sources:
1. https://www.quviviq.com/cost-and-savings
2. https://www.quviviq.com/
3. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8688957/
4. https://drugpatentwatch.com/